Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 103, Issue 2, Pages 202-205Publisher
WILEY
DOI: 10.1002/cpt.946
Keywords
-
Categories
Ask authors/readers for more resources
The role of real-world evidence (RWE) in regulatory, drug development, and healthcare decision-making is rapidly expanding. Recent advances have increased the complexity of cancer care and widened the gap between randomized clinical trial (RCT) results and the evidence needed for real-world clinical decisions. Instead of remaining invisible, data from the >95% of cancer patients treated outside of clinical trials can help fill this void.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available